IAS 2015 David Wyles at IAS 2015. Photo by Liz Highleyman, hivandhepatitis.comTreatment for people living with HIV and HCVInterferon-free hepatitis treatment is highly effective for people with co-infection Laurence Brunet at IAS 2015. Photo by Liz Highleyman, hivandhepatitis.comTreatment outcomesLiver fibrosis regression after hepatitis C treatment linked to reduced complications & death in people with HIV/HCV co-infection Panel on hepatitis treatment access. Photo by Liz Highleyman, hivandhepatitis.comAccess to screening and treatmentNews from the Second International HIV/Viral Hepatitis Co-infection Meeting infohep news Treatment for people living with HIV and HCV Interferon-free hepatitis treatment is highly effective for people with HIV and HCV co-infection in three studies Liz Highleyman / 10 August 2015 Three different interferon-free regimens – sofosbuvir/ledipasvir, AbbVie's 3D regimen and grazoprevir/elbasvir – were well-tolerated and cured more than 90% of participants with HIV and HCV co-infection in three clinical trials, confirming that HIV-positive ... Treatment outcomes Liver fibrosis regression after hepatitis C treatment linked to reduced complications and death in people with HIV and HCV co-infection Liz Highleyman / 06 August 2015 People with HIV and HCV co-infection, with liver cirrhosis, who achieve sustained virological response (SVR) and experience an improvement in liver fibrosis are less likely to develop liver disease complications or die from ... Treatment for people living with HIV and HCV Daclatasvir plus sofosbuvir cures HCV for most people with HIV and HCV co-infection in French compassionate use programme Liz Highleyman / 05 August 2015 Interferon-free treatment using daclatasvir (Daklinza) and sofosbuvir (Sovaldi), with or without ribavirin, was well-tolerated and produced sustained virological response rates of 95-100% for people with HIV and HCV co-infection and advanced liver disease, ... Treatment for people living with HIV and HCV Access to screening and treatment are key issues for hepatitis B and C and HIV/viral hepatitis co-infection Liz Highleyman / 04 August 2015 The development of effective new interferon-free treatment makes it possible to cure more than 90% of people with chronic hepatitis C, including most people with HIV and hepatitis C virus (HCV) co-infection, researchers ... View more > Editors' picks from other sources View more > Other pages in this section Latest news All the news Conference news Email bulletin archive